Identification of IL-27 as a novel regulator of major histocompatibility complex class I and class II expression, antigen presentation, and processing in intestinal epithelial cells

Antigen presentation via major histocompatibility complex (MHC) class I and class II receptors plays a fundamental role in T cell-mediated adaptive immunity. A dysregulation of this fine-tuned recognition might result in the development of autoimmune diseases such as inflammatory bowel diseases that...

Full description

Bibliographic Details
Main Authors: Julia Diegelmann, Stephan Brand
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-09-01
Series:Frontiers in Immunology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2023.1226809/full
_version_ 1797673970639568896
author Julia Diegelmann
Julia Diegelmann
Stephan Brand
Stephan Brand
author_facet Julia Diegelmann
Julia Diegelmann
Stephan Brand
Stephan Brand
author_sort Julia Diegelmann
collection DOAJ
description Antigen presentation via major histocompatibility complex (MHC) class I and class II receptors plays a fundamental role in T cell-mediated adaptive immunity. A dysregulation of this fine-tuned recognition might result in the development of autoimmune diseases such as inflammatory bowel diseases that are characterized by chronic relapsing inflammation of the intestinal tract and a damaged intestinal epithelial barrier. While MHCII receptors are usually expressed by professional antigen presenting cells (APC) only, there is increasing evidence that non-immune cells such as intestinal epithelial cells (IEC) might express MHCII upon stimulation with IFN-γ and thus act as non-professional APC. However, little is known about other factors regulating intestinal epithelial MHC expression. Here, we identify IL-27 as an inducer of different MHCI and MHCII receptor subtypes and the invariant chain (CD74/li) in IEC via the STAT1/IRF1/CIITA axis. CIITA, MHCII, and CD74 expression was significantly increased in IEC from Crohn’s disease (CD) patients with active disease compared to controls or CD patients in remission. IEC phagocytosed and digested external antigens and apoptotic cells. IL-27 strongly stimulated antigen processing via the immunoproteasome in a IRF1-dependent manner. In co-culture experiments, antigen-primed IEC strongly enhanced lymphocyte proliferation and IL-2 secretion, dependent on direct cell-cell contact. IL-27 pretreatment of IEC significantly increased CD4+ T cell proliferation and reduced IL-2 levels in lymphocytes in coculture. In summary, we identified IL-27 as a novel regulator of IEC antigen processing and presentation via MHCI and MHCII receptors, underscoring the importance of IEC as non-professional APC.
first_indexed 2024-03-11T21:53:20Z
format Article
id doaj.art-143614b7fa8d4a849de497fe41d363f9
institution Directory Open Access Journal
issn 1664-3224
language English
last_indexed 2024-03-11T21:53:20Z
publishDate 2023-09-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Immunology
spelling doaj.art-143614b7fa8d4a849de497fe41d363f92023-09-26T05:54:24ZengFrontiers Media S.A.Frontiers in Immunology1664-32242023-09-011410.3389/fimmu.2023.12268091226809Identification of IL-27 as a novel regulator of major histocompatibility complex class I and class II expression, antigen presentation, and processing in intestinal epithelial cellsJulia Diegelmann0Julia Diegelmann1Stephan Brand2Stephan Brand3Department of Medicine II, Ludwig-Maximilians-Universität (LMU) University Hospital, LMU Munich, Munich, GermanyDepartment of Conservative Dentistry and Periodontology, LMU University Hospital, LMU Munich, Munich, GermanyDepartment of Medicine II, Ludwig-Maximilians-Universität (LMU) University Hospital, LMU Munich, Munich, GermanyDepartment of Gastroenterology and Hepatology, Kantonsspital St. Gallen, St. Gallen, SwitzerlandAntigen presentation via major histocompatibility complex (MHC) class I and class II receptors plays a fundamental role in T cell-mediated adaptive immunity. A dysregulation of this fine-tuned recognition might result in the development of autoimmune diseases such as inflammatory bowel diseases that are characterized by chronic relapsing inflammation of the intestinal tract and a damaged intestinal epithelial barrier. While MHCII receptors are usually expressed by professional antigen presenting cells (APC) only, there is increasing evidence that non-immune cells such as intestinal epithelial cells (IEC) might express MHCII upon stimulation with IFN-γ and thus act as non-professional APC. However, little is known about other factors regulating intestinal epithelial MHC expression. Here, we identify IL-27 as an inducer of different MHCI and MHCII receptor subtypes and the invariant chain (CD74/li) in IEC via the STAT1/IRF1/CIITA axis. CIITA, MHCII, and CD74 expression was significantly increased in IEC from Crohn’s disease (CD) patients with active disease compared to controls or CD patients in remission. IEC phagocytosed and digested external antigens and apoptotic cells. IL-27 strongly stimulated antigen processing via the immunoproteasome in a IRF1-dependent manner. In co-culture experiments, antigen-primed IEC strongly enhanced lymphocyte proliferation and IL-2 secretion, dependent on direct cell-cell contact. IL-27 pretreatment of IEC significantly increased CD4+ T cell proliferation and reduced IL-2 levels in lymphocytes in coculture. In summary, we identified IL-27 as a novel regulator of IEC antigen processing and presentation via MHCI and MHCII receptors, underscoring the importance of IEC as non-professional APC.https://www.frontiersin.org/articles/10.3389/fimmu.2023.1226809/fullintestinal epithelial cellsIL-27MHC receptorantigen presentationinflammatory bowel diseaseintestinal inflammation
spellingShingle Julia Diegelmann
Julia Diegelmann
Stephan Brand
Stephan Brand
Identification of IL-27 as a novel regulator of major histocompatibility complex class I and class II expression, antigen presentation, and processing in intestinal epithelial cells
Frontiers in Immunology
intestinal epithelial cells
IL-27
MHC receptor
antigen presentation
inflammatory bowel disease
intestinal inflammation
title Identification of IL-27 as a novel regulator of major histocompatibility complex class I and class II expression, antigen presentation, and processing in intestinal epithelial cells
title_full Identification of IL-27 as a novel regulator of major histocompatibility complex class I and class II expression, antigen presentation, and processing in intestinal epithelial cells
title_fullStr Identification of IL-27 as a novel regulator of major histocompatibility complex class I and class II expression, antigen presentation, and processing in intestinal epithelial cells
title_full_unstemmed Identification of IL-27 as a novel regulator of major histocompatibility complex class I and class II expression, antigen presentation, and processing in intestinal epithelial cells
title_short Identification of IL-27 as a novel regulator of major histocompatibility complex class I and class II expression, antigen presentation, and processing in intestinal epithelial cells
title_sort identification of il 27 as a novel regulator of major histocompatibility complex class i and class ii expression antigen presentation and processing in intestinal epithelial cells
topic intestinal epithelial cells
IL-27
MHC receptor
antigen presentation
inflammatory bowel disease
intestinal inflammation
url https://www.frontiersin.org/articles/10.3389/fimmu.2023.1226809/full
work_keys_str_mv AT juliadiegelmann identificationofil27asanovelregulatorofmajorhistocompatibilitycomplexclassiandclassiiexpressionantigenpresentationandprocessinginintestinalepithelialcells
AT juliadiegelmann identificationofil27asanovelregulatorofmajorhistocompatibilitycomplexclassiandclassiiexpressionantigenpresentationandprocessinginintestinalepithelialcells
AT stephanbrand identificationofil27asanovelregulatorofmajorhistocompatibilitycomplexclassiandclassiiexpressionantigenpresentationandprocessinginintestinalepithelialcells
AT stephanbrand identificationofil27asanovelregulatorofmajorhistocompatibilitycomplexclassiandclassiiexpressionantigenpresentationandprocessinginintestinalepithelialcells